FDA approves Zepbound for sleep apnea in obese adults
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
Hosted on MSN1h
Health Benefits or Negative Impacts Still Uncertain for Most Supplements
Lining grocery store shelves are supplements like omega fish oil, goat's rue and others that sound more like the ingredients ...
Changing your eye color with surgery is risky. They did it anyway.
Advances in cosmetic surgery let people permanently change their eye color, and they’ll pay thousands for a new hue. Doctors ...
For young users, tobacco packets like Zyn are a nicotine trend that just won’t quit
Promoted by users as a pick-me-up, nicotine may give young people a quick burst of energy. But in the long term, it has the ...
FDA recalls hair spray brand in 12 states over solvent linked to health risks
Initially the hair spray brand was a voluntarily recalled by CRLAB USA, based in California, on Dec. 12 and became a Class II ...
The Takeout on MSN3h
Bottled Water Recalls That Affected Millions
Bottle water brands market their product as being pure and natural ... but that's not always the case, as explained in this ...
wjactv2h
FDA issues temporary recall of new Gardners 'Cappuccino Meltaway' candy bars
BLAIR COUNTY, Pa (WJAC) — The U.S. Food and Drug Administration (FDA) has issued a temporary recall of the latest Gardners ...
News Nation on MSN4h
Weight loss drug Zepbound approved to help sleep apnea patients
( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...
STAT5h
Fixing pulse oximeters requires federal might and possible legal action, researchers say
The devices remain unreliable in darker skinned people. Researchers say more guidance, enforcement and even legal action may ...
Could the FDA's Approach to Vaping Cause an Increase in Smoking?
In early December, the Supreme Court heard oral argument in Food and Drug Administration v. Wages and White Lion Investments, a challenge to the FDA's ...
STAT8h
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
Five Policy Changes That Could Impact US Businesses In 2025
Business leaders continue to grapple with uncertainty, not only about the post-election economic and geopolitical landscape ...